Restore Mind Medicine

MindMed "On-Track" Since January, MindMed has continued to repeat that they are on track: but they have always been trying to catch-up. Q "50% of patients dosed across 20 active clinical sites" May 18, 2023. MindMed's Press Release Announcing Enrollment I "the [Phase 2b study] remains on track" May 4, 2023. MindMed's Press Release Announcing Q1 2023 Results "Phase 2b study evaluating MM-120 for generalized anxiety disorder ("GAD") remains on track" March 2023. Annual Report Press Release "Phase 2b study evaluating MM-120 for generalized anxiety disorder remains on track" January 9, 2023. MindMed Press Release 36

View entire presentation